Korczynski Sherry
Korczynski Sherry, CCO, reported a transaction classified as exercise at Aquestive Therapeutics, Inc. involving 8750.000000 shares for an estimated $23187.50. Reported holdings after the transaction were 244439.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 09, 2026
- Filing date
- Sep 11, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
AQST price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001214659-26-011596 Common Stock
- Transaction date
- Sep 09, 2026 Filed Sep 11, 2026, 03:07 PM · 2d delay
- Shares
- 8,750 sh $2.65 per share
- Estimated value
- $23.1k Computed from shares × price
- Holdings after
- 244,439 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Commercial Officer
- F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.
- F2
The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
0 other transactions
0 recent txs